Measuring the drug and its metabolites to understand the interactions with the body. **Learn more about the bioanalytical lab below or advance to the next page to move on to the biomarker lab**
Over the past three decades, PPD Laboratories’ bioanalytical lab has helped bring thousands of compounds to market by employing the most technologically advanced systems to develop assays and apply them to clinical trial samples across every stage of drug development. Our more than 1,200 scientists and staff provide services small molecules, biologics, vaccines and cell and gene therapies, leveraging two laboratory locations in Richmond, Virginia and Middleton, Wisconsin and industry-leading instrumentation and automation.
PPD Laboratories’ bioanalytical lab has successfully completed more than 70 regulatory inspections over the past three decades, including audits of multiple biosimilar programs such as insulin, adalimumab, etanercept and pegfilgrastim. As a result, we can quickly anticipate and overcome potential regulatory challenges due to evolving expectations for bioanalytical clinical data sets that could pose obstacles to regulatory approvals.
Contact us to learn more
At PPD Laboratories, our integrated approach leverages our extensive bioanalytical experience to enhance the expertise of the vaccine sciences and biomarker teams. Projects utilizing our central lab can also have data and project teams integrated, which provides additional levels of visibility for key project metrics and real-time access to select data sets to enable you to make faster and better decisions about your compound.
Take a tour of our bioanalytical lab in Richmond, VA >
